Conference Coverage

How to beat apremilast-induced diarrhea

Publish date: March 31, 2016

 

EXPERT ANALYSIS FROM RWCS 2016

References

He reported serving on scientific advisory boards for, and/or as a consultant to, nine pharmaceutical companies.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Registry shows no increased cancer risk with biologics for psoriasis
Psoriasis Collection
NNTs show once-unimaginable psoriasis outcomes now readily attainable
Psoriasis Collection
Subclinical inflammation predicts progression from psoriasis to PsA
Psoriasis Collection
Brodalumab met primary endpoints, deaths called ‘unrelated’
Psoriasis Collection
Minimal disease activity criteria in PsA fall short
Psoriasis Collection
60 weeks of ixekizumab effective, well tolerated in moderate-to-severe plaque psoriasis
Psoriasis Collection
Don’t overlook topical tazarotene for psoriasis
Psoriasis Collection
Fresh evidence of methotrexate efficacy in psoriatic arthritis
Psoriasis Collection
Sparse, poor evidence supports fumarates for psoriasis
Psoriasis Collection
Ixekizumab approved for plaque psoriasis
Psoriasis Collection